{"id":"NCT04093752","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)","officialTitle":"A Randomized, Phase 3, Open-label Trial Comparing the Effect of Tirzepatide Once Weekly Versus Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes on Metformin With or Without a Sulfonylurea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-12-09","primaryCompletion":"2021-11-01","completion":"2021-11-24","firstPosted":"2019-09-18","resultsPosted":"2023-01-06","lastUpdate":"2023-01-06"},"enrollment":917,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Tirzepatide","otherNames":["LY3298176"]},{"type":"DRUG","name":"Insulin Glargine","otherNames":[]}],"arms":[{"label":"5 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"10 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"15 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"Insulin Glargine","type":"ACTIVE_COMPARATOR"}],"summary":"The main reason for this study is to compare the study drug tirzepatide to insulin glargine in participants with type 2 diabetes on metformin with or without a sulfonylurea.","primaryOutcome":{"measure":"Mean Change From Baseline in Hemoglobin A1c (HbA1c) (10 mg and 15 mg)","timeFrame":"Baseline, Week 40","effectByArm":[{"arm":"10 mg Tirzepatide","deltaMin":-2.44,"sd":0.073},{"arm":"15 mg Tirzepatide","deltaMin":-2.49,"sd":0.072},{"arm":"Insulin Glargine","deltaMin":-0.95,"sd":0.073}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":9},"locations":{"siteCount":67,"countries":["Australia","China","India","South Korea"]},"refs":{"pmids":["38494574","37231074"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":230},"commonTop":["Decreased appetite","Diarrhoea","Nausea","Hyperuricaemia","Lipase increased"]}}